keyword
https://read.qxmd.com/read/37795079/reconciling-intrinsic-properties-of-activating-tnf-receptors-by-native-ligands-versus-synthetic-agonists
#21
REVIEW
George Fromm, Suresh de Silva, Taylor H Schreiber
The extracellular domain of tumor necrosis factor receptors (TNFR) generally require assembly into a homotrimeric quaternary structure as a prerequisite for initiation of signaling via the cytoplasmic domains. TNF receptor homotrimers are natively activated by similarly homo-trimerized TNF ligands, but can also be activated by synthetic agonists including engineered antibodies and Fc-ligand fusion proteins. A large body of literature from pre-clinical models supports the hypothesis that synthetic agonists targeting a diverse range of TNF receptors (including 4-1BB, CD40, OX40, GITR, DR5, TNFRSF25, HVEM, LTβR, CD27, and CD30) could amplify immune responses to provide clinical benefit in patients with infectious diseases or cancer...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37725855/dna-damage-repair-profiling-of-esophageal-squamous-cell-carcinoma-uncovers-clinically-relevant-molecular-subtypes-with-distinct-prognoses-and-therapeutic-vulnerabilities
#22
JOURNAL ARTICLE
Ning Zhao, Zicheng Zhang, Qiang Wang, Lin Li, Zichao Wei, Hongyan Chen, Meng Zhou, Zhihua Liu, Jianzhong Su
BACKGROUND: DNA damage repair (DDR) is a critical process that maintains genomic integrity and plays essential roles at both the cellular and organismic levels. Here, we aimed to characterize the DDR profiling of esophageal squamous cell carcinoma (ESCC), investigate the prognostic value of DDR-related features, and explore their potential for guiding personalized treatment strategies. METHODS: We analyzed bulk and single-cell transcriptomics data from 377 ESCC cases from our institution and other publicly available cohorts to identify major DDR subtypes...
September 17, 2023: EBioMedicine
https://read.qxmd.com/read/37713507/lung-tumor-infiltrating-t-reg-have-divergent-transcriptional-profiles-and-function-linked-to-checkpoint-blockade-response
#23
JOURNAL ARTICLE
Arbor G Dykema, Jiajia Zhang, Laurene S Cheung, Sydney Connor, Boyang Zhang, Zhen Zeng, Christopher M Cherry, Taibo Li, Justina X Caushi, Marni Nishimoto, Andrew J Munoz, Zhicheng Ji, Wenpin Hou, Wentao Zhan, Dipika Singh, Tianbei Zhang, Rufiaat Rashid, Marisa Mitchell-Flack, Sadhana Bom, Ada Tam, Nick Ionta, Thet H K Aye, Yi Wang, Camille A Sawosik, Lauren E Tirado, Luke M Tomasovic, Derek VanDyke, Jamie B Spangler, Valsamo Anagnostou, Stephen Yang, Jonathan Spicer, Roni Rayes, Janis Taube, Julie R Brahmer, Patrick M Forde, Srinivasan Yegnasubramanian, Hongkai Ji, Drew M Pardoll, Kellie N Smith
Regulatory T cells (Treg ) are conventionally viewed as suppressors of endogenous and therapy-induced antitumor immunity; however, their role in modulating responses to immune checkpoint blockade (ICB) is unclear. In this study, we integrated single-cell RNA-seq/T cell receptor sequencing (TCRseq) of >73,000 tumor-infiltrating Treg (TIL-Treg ) from anti-PD-1-treated and treatment-naive non-small cell lung cancers (NSCLC) with single-cell analysis of tumor-associated antigen (TAA)-specific Treg derived from a murine tumor model...
September 15, 2023: Science Immunology
https://read.qxmd.com/read/37669115/regulatory-t-cells-integrate-native-and-car-mediated-co-stimulatory-signals-for-control-of-allograft-rejection
#24
JOURNAL ARTICLE
Isaac Rosado-Sánchez, Manjurul Haque, Kevin Salim, Madeleine Speck, Vivian Cw Fung, Dominic A Boardman, Majid Mojibian, Giorgio Raimondi, Megan K Levings
Regulatory T cells (Tregs) expressing Chimeric Antigen Receptors (CARs) are a promising tool to promote transplant tolerance. The relationship between CAR structure and Treg function was studied in xenogeneic, immunodeficient mice, revealing advantages of CD28-encoding CARs. However, these models could underrepresent interactions between CAR-Tregs, antigen-presenting cells (APCs) and donor-specific antibodies. We generated Tregs expressing HLA-A2-specific CARs with different costimulatory domains and compared their function in vitro and in vivo using an immunocompetent model of transplantation...
September 5, 2023: JCI Insight
https://read.qxmd.com/read/37667956/prognostic-and-predictive-significance-of-gitr-in-metastatic-renal-cell-carcinoma
#25
JOURNAL ARTICLE
O Y Balçık, D Akın, G S Ceylan, B Demİr, A Aytaç, N Çulhacı, E Oktay
OBJECTIVE: Renal cell carcinoma (RCC) has gradually increased in recent years. There have been significant developments in metastatic RCC in recent years with the introduction of immune control point inhibitors. Glucocorticoid-induced tumor necrosis factor (TNF) receptor-related protein (GITR) is a co-stimulatory molecule and is seen in the highest amounts in activated CD4+ T lymphocytes and CD8+ T lymphocytes, forkhead box protein 3 (FOXP3) positive regulatory T cells (Treg). GITR leads to an increase in interleukin (IL)-2 and CD25 and Interferon Gamma...
August 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/37553332/t-cell-priming-transcriptomic-markers-implications-of-immunome-heterogeneity-for-precision-immunotherapy
#26
JOURNAL ARTICLE
Hirotaka Miyashita, Razelle Kurzrock, Nicholas J Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean T Glenn, Jeffrey M Conroy, Paul DePietro, Eitan Rubin, Jason K Sicklick, Shumei Kato
Immune checkpoint blockade is effective for only a subset of cancers. Targeting T-cell priming markers (TPMs) may enhance activity, but proper application of these agents in the clinic is challenging due to immune complexity and heterogeneity. We interrogated transcriptomics of 15 TPMs (CD137, CD27, CD28, CD80, CD86, CD40, CD40LG, GITR, ICOS, ICOSLG, OX40, OX40LG, GZMB, IFNG, and TBX21) in a pan-cancer cohort (N = 514 patients, 30 types of cancer). TPM expression was analyzed for correlation with histological type, microsatellite instability high (MSI-H), tumor mutational burden (TMB), and programmed death-ligand 1 (PD-L1) expression...
August 8, 2023: NPJ Genomic Medicine
https://read.qxmd.com/read/37488117/multidirectional-characterization-of-cellular-composition-and-spatial-architecture-in-human-multiple-primary-lung-cancers
#27
JOURNAL ARTICLE
Yawei Wang, Di Chen, Yu Liu, Daiwang Shi, Chao Duan, Jinghan Li, Xiang Shi, Yong Zhang, Zhanwu Yu, Nan Sun, Wei Wang, Yegang Ma, Xiaohan Xu, Wuxiyar Otkur, Xiaolong Liu, Tian Xia, Huan Qi, Hai-Long Piao, Hong-Xu Liu
Multiple primary lung cancers (MPLCs) pose diagnostic and therapeutic challenges in clinic. Here, we orchestrated the cellular and spatial architecture of MPLCs by combining single-cell RNA-sequencing and spatial transcriptomics. Notably, we identified a previously undescribed sub-population of epithelial cells termed as CLDN2+ alveolar type II (AT2) which was specifically enriched in MPLCs. This subtype was observed to possess a relatively stationary state, play a critical role in cellular communication, aggregate spatially in tumor tissues, and dominate the malignant histopathological patterns...
July 25, 2023: Cell Death & Disease
https://read.qxmd.com/read/37468118/effects-of-ruxolitinib-on-murine-regulatory-t-cells-are-immune-context-dependent
#28
JOURNAL ARTICLE
Nidhi Aggarwal, Ash Lee Manley, Jichun Chen, Emma M Groarke, Xingmin Feng, Neal S Young
Aplastic anemia is a bone marrow failure (BMF) disorder characterized by pancytopenia and hypocellular marrow from an immune-mediated etiology. Regulatory T cells (Tregs) prevent autoimmunity by suppressing autoreactive T cells. We recently demonstrated the efficacy of ruxolitinib, a JAK 1/2 inhibitor, in attenuating murine BMF. Herein, we investigated the changes of Tregs in the context of ruxolitinib treatment for murine BMF. Tregs are conventionally identified by surface expression of CD4 and CD25, in addition to intracellular transcription factor FoxP3...
July 17, 2023: Experimental Hematology
https://read.qxmd.com/read/37446055/car-modified-v%C3%AE-9v%C3%AE-2-t-cells-propagated-using-a-novel-bisphosphonate-prodrug-for-allogeneic-adoptive-immunotherapy
#29
JOURNAL ARTICLE
Yizheng Wang, Linan Wang, Naohiro Seo, Satoshi Okumura, Tae Hayashi, Yasushi Akahori, Hiroshi Fujiwara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Yoshimasa Tanaka, Takuma Kato, Hiroshi Shiku
The benefits of CAR-T therapy could be expanded to the treatment of solid tumors through the use of derived autologous αβ T cell, but clinical trials of CAR-T therapy for patients with solid tumors have so far been disappointing. CAR-T therapy also faces hurdles due to the time and cost intensive preparation of CAR-T cell products derived from patients as such CAR-T cells are often poor in quality and low in quantity. These inadequacies may be mitigated through the use of third-party donor derived CAR-T cell products which have a potent anti-tumor function but a constrained GVHD property...
June 29, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37371066/fundamental-characterization-of-antibody-fusion-single-chain-tnf-recombinant-proteins-directed-against-costimulatory-tnf-receptors-expressed-by-t-lymphocytes
#30
JOURNAL ARTICLE
Hodaka Nagai, Mitsuki Azuma, Ayaka Sato, Nagito Shibui, Sayaka Ogawara, Yuta Tsutsui, Ayano Suzuki, Tomomi Wakaizumi, Aya Ito, Shimpei Matsuyama, Masashi Morita, Mari Hikosaka Kuniishi, Naoto Ishii, Takanori So
The costimulatory signal regulated by the members of the tumor necrosis factor receptor (TNFR) superfamily expressed by T cells plays essential roles for T cell responses and has emerged as a promising target for cancer immunotherapy. However, it is unclear how the difference in TNFR costimulation contributes to T cell responses. In this study, to clarify the functional significance of four different TNFRs, OX40, 4-1BB, CD27 and GITR, we prepared corresponding single-chain TNF ligand proteins (scTNFLs) connected to IgG Fc domain with beneficial characteristics, i...
June 9, 2023: Cells
https://read.qxmd.com/read/37335294/targeting-gitr-in-cancer-immunotherapy-there-is-no-perfect-knowledge
#31
JOURNAL ARTICLE
Diwakar Davar, Roberta Zappasodi
Glucocorticoid-induced TNFR-related protein (GITR) belongs to the TNFR superfamily (TNFRSF) and stimulates both the acquired and innate immunity. GITR is broadly expressed on immune cells, particularly regulatory T cells (Tregs) and natural killer (NK) cells. Given its potential to promote T effector function and impede Treg immune suppression, GITR is an attractive target for cancer immunotherapy. Preclinically, GITR agonists have demonstrated potent anti-tumor efficacy singly and in combination with a variety of agents, including PD-1 blockade...
June 19, 2023: Oncotarget
https://read.qxmd.com/read/37256126/prediction-of-risk-and-overall-survival-of-pancreatic-cancer-from-blood-soluble-immune-checkpoint-related-proteins
#32
JOURNAL ARTICLE
Sai Pan, Wenting Zhao, Yizhan Li, Zhijun Ying, Yihong Luo, Qinchuan Wang, Xiawei Li, Wenjie Lu, Xin Dong, Yulian Wu, Xifeng Wu
BACKGROUND: Immune checkpoint inhibition holds promise as a novel treatment for pancreatic ductal adenocarcinoma (PDAC). The clinical significance of soluble immune checkpoint (ICK) related proteins have not yet fully explored in PDAC. METHODS: We comprehensively profiled 14 soluble ICK-related proteins in plasma in 70 PDAC patients and 70 matched healthy controls. Epidemiological data of all subjects were obtained through structured interviews, and patients' clinical data were retrieved from electronical health records...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37216704/predictive-plasma-biomarkers-of-long-term-increase-in-hepatic-steatosis-index-after-hcv-eradication-in-hiv-hcv-coinfected-patients
#33
JOURNAL ARTICLE
Rubén Martín-Escolano, Ana Virseda-Berdices, Juan Berenguer, Juan González-García, Oscar Brochado-Kith, Amanda Fernández-Rodríguez, Cristina Díez, Victor Hontañon, Salvador Resino, María Ángeles Jiménez-Sousa
Hepatic steatosis is a common condition found in the liver of hepatitis C virus (HCV)-infected patients, contributing to more severe forms of liver disease. In addition, the human immunodeficiency virus (HIV) may accelerate this process. Alternatively, several immune checkpoint proteins have been reported to be upregulated and correlated with disease progression during HCV and HIV infections. In steatosis, a detrimental immune system activation has been established; however, the role of the immune checkpoints has not been addressed so far...
May 20, 2023: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/37182149/antibody-based-cancer-immunotherapy-by-targeting-regulatory-t-cells
#34
REVIEW
Quanxiao Li, Jun Lu, Jinyao Li, Baohong Zhang, Yanling Wu, Tianlei Ying
Regulatory T cells (Tregs) are among the most abundant suppressive cells, which infiltrate and accumulate in the tumor microenvironment, leading to tumor escape by inducing anergy and immunosuppression. Their presence has been correlated with tumor progression, invasiveness and metastasis. Targeting tumor-associated Tregs is an effective addition to current immunotherapy approaches, but it may also trigger autoimmune diseases. The major limitation of current therapies targeting Tregs in the tumor microenvironment is the lack of selective targets...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37090741/targeting-immune-checkpoints-in-anti-neutrophil-cytoplasmic-antibodies-associated-vasculitis-the-potential-therapeutic-targets-in-the-future
#35
REVIEW
Menglu Pan, Huanhuan Zhao, Ruimin Jin, Patrick S C Leung, Zongwen Shuai
Anti-neutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) is a necrotizing vasculitis mainly involving small blood vessels. It is demonstrated that T cells are important in the pathogenesis of AAV, including regulatory T cells (Treg) and helper T cells (Th), especially Th2, Th17, and follicular Th cells (Tfh). In addition, the exhaustion of T cells predicted the favorable prognosis of AAV. The immune checkpoints (ICs) consist of a group of co-stimulatory and co-inhibitory molecules expressed on the surface of T cells, which maintains a balance between the activation and exhaustion of T cells...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37064132/dysregulation-of-systemic-soluble-immune-checkpoints-in-early-breast-cancer-is-attenuated-following-administration-of-neoadjuvant-chemotherapy-and-is-associated-with-recovery-of-cd27-cd28-cd40-cd80-icos-and-gitr-and-substantially-increased-levels-of-pd-l1-lag
#36
JOURNAL ARTICLE
Bernardo L Rapoport, Helen C Steel, Carol A Benn, Simon Nayler, Teresa Smit, Liezl Heyman, Annette J Theron, Nomsa Hlatshwayo, Luyanda L I Kwofie, Pieter W A Meyer, Ronald Anderson
Neoadjuvant chemotherapy (NAC) may alter the immune landscape of patients with early breast cancer (BC), potentially setting the scene for more effective implementation of checkpoint-targeted immunotherapy. This issue has been investigated in the current study in which alterations in the plasma concentrations of 16 soluble co-stimulatory and co-inhibitory, immune checkpoints were measured sequentially in a cohort of newly diagnosed, early BC patients (n=72), pre-treatment, post-NAC and post-surgery using a Multiplex® bead array platform...
2023: Frontiers in Oncology
https://read.qxmd.com/read/37035756/t-cell-subsets-and-the-expression-of-related-micrornas-in-patients-with-recurrent-early-pregnancy-loss
#37
JOURNAL ARTICLE
Ya-Ni Yan, Jian Zhang, Na Yang, Chaochao Chen, Weiwei Li
This study explored the role of T cell subsets and the expression of related microRNAs in patients with recurrent early pregnancy loss (EPL). Fifty patients with EPL loss between May 2018 and May 2021 were randomly selected as the EPL group, and 50 pregnant women with normal pregnancies or normal delivery outcomes were randomly selected as the control group. The expression levels of T cell subset-related markers and T cell subset-related miRNAs, in addition to the frequencies of T cell subsets, in peripheral blood of the two groups were analyzed...
2023: Mediators of Inflammation
https://read.qxmd.com/read/37018706/asymmetric-transfer-hashing-with-adaptive-bipartite-graph-learning
#38
JOURNAL ARTICLE
Jianglin Lu, Jie Zhou, Yudong Chen, Witold Pedrycz, Kwok-Wai Hung
Thanks to the efficient retrieval speed and low storage consumption, learning to hash has been widely used in visual retrieval tasks. However, the known hashing methods assume that the query and retrieval samples lie in homogeneous feature space within the same domain. As a result, they cannot be directly applied to heterogeneous cross-domain retrieval. In this article, we propose a generalized image transfer retrieval (GITR) problem, which encounters two crucial bottlenecks: 1) the query and retrieval samples may come from different domains, leading to an inevitable domain distribution gap and 2) the features of the two domains may be heterogeneous or misaligned, bringing up an additional feature gap...
January 11, 2023: IEEE Transactions on Cybernetics
https://read.qxmd.com/read/36993756/gitr-and-tigit-immunotherapy-provokes-divergent-multi-cellular-responses-in-the-tumor-microenvironment-of-gastrointestinal-cancers
#39
Anuja Sathe, Carlos Ayala, Xiangqi Bai, Susan M Grimes, Byrne Lee, Cindy Kin, Andrew Shelton, George Poultsides, Hanlee P Ji
Understanding the cellular mechanisms of novel immunotherapy agents in the human tumor microenvironment ( TME ) is critical to their clinical success. We examined GITR and TIGIT immunotherapy in gastric and colon cancer patients using ex vivo slice tumor slice cultures derived from cancer surgical resections. This primary culture system maintains the original TME in a near-native state. We applied paired single-cell RNA and TCR sequencing to identify cell type specific transcriptional reprogramming. The GITR agonist was limited to increasing effector gene expression only in cytotoxic CD8 T cells...
March 15, 2023: bioRxiv
https://read.qxmd.com/read/36863094/pharmacodynamic-activity-of-bms-986156-a-glucocorticoid-induced-tnf-receptor-related-protein-agonist-alone-or-in-combination-with-nivolumab-in-patients-with-advanced-solid-tumors
#40
JOURNAL ARTICLE
R Wang, V Baxi, Z Li, D Locke, C Hedvat, Y Sun, A M Walsh, X Shao, T Basavanhally, D M Greenawalt, P Patah, R Novosiadly
BACKGROUND: The success of immune checkpoint inhibitors has revolutionized cancer treatment options and triggered development of new complementary immunotherapeutic strategies, including T-cell co-stimulatory molecules, such as glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR). BMS-986156 is a fully agonistic human immunoglobulin G subclass 1 monoclonal antibody targeting GITR. We recently presented the clinical data for BMS-986156 with or without nivolumab, which demonstrated no compelling evidence of clinical activity in patients with advanced solid tumors...
February 28, 2023: ESMO Open
keyword
keyword
71893
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.